Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid
Kurzübersicht für Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid (ABIN8106320)
Target
Quelle
Applikation
-
-
Verwendungszweck
- NOVA1 Peptide
-
-
Neuro-Oncological Ventral Antigen 1 (NOVA1) peptide
NOVA1 Reaktivität: Human Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-NOVA1 antibody ( ARP40397_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Hintergrund
-
Background Information: NOVA1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer.This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.
Alternative Symbols: Nova-1
-
Molekulargewicht
- 52kDa
-
Gen-ID
- 4857
-
NCBI Accession
- NP_002506
-
UniProt
- A8K603
Target
-
